using steroids to manage immunotherapy-associated aes in melanoma
Published 4 years ago • 263 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
1:50
nuances of immunotherapy-related aes in melanoma
-
7:24
immunotherapy in melanoma: recognizing an endocrinopathy
-
10:54
immunotherapy in melanoma
-
1:41
kathleen m. madden on managing aes from targeted therapies for melanoma
-
1:40
rajni kannan discusses managing aes from combination therapies in melanoma
-
4:33
overall toxicities with immunotherapy in melanoma
-
2:43
less common side effects with immunotherapy in melanoma
-
10:35
measuring response to immunotherapy in melanoma
-
2:44
less common side effects with immunotherapy in melanoma
-
24:07
the issue of steroid use with immune checkpoint inhibition: alessandra curioni
-
1:36
why high dose steroids create a reduced response to immunotherapy
-
0:53
managing immunotherapy toxicities in melanoma
-
7:23
immunotherapy in melanoma: recognizing an endocrinopathy
-
0:56
dr. lopes discusses steroid side effects in lung cancer management
-
4:48
minimizing the risk of steroid-induced hyperglycemia in nsclc patients receiving immunotherapy
-
6:21
melanoma: helping patients understand immunotherapy
-
2:15
dr. sullivan on immunotherapy approaches in melanoma
-
7:55
mrcc: identifying and managing aes in tkis and io therapy
-
5:15
managing braf inhibitor associated skin toxicity